Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. - Drug 2026-12-31
Ethiopia Armauer Hansen Research Institute Invites Eligible Bidders For The Procurement Of Medical Supplies /regents/ 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-12-31
Germany Tender Are Invited For Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House P 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Social Security Code V For Medicinal Products Containing The Active Ingredient Trientine (a16ax12) Within The Framework Of A So-called Open House Model. 2026-12-31
Germany Tender Are Invited For Medicinal Products Containing The Active Ingredient Ritonavir (j05ae03) as Part Of A So-called Open-house Model. 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Tadalafil (g04be08), Only Medicinal Products With The Indication Benign Prostatic Syndrome 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Trientine (a16ax12) as Part Of A So-called Open-house Model. 2026-12-31
Whats app